EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Identification and validation of a glutamine metabolism-related gene signature as a diagnostic and therapeutic target in osteoarthritis through integrated multi-omics analysis

Yang Lu, Jinkun Liu, Shasha Wang, Jianping Gan, Wenfu Cao, Bin Wu

PeerJ · 2026

DOI: 10.7717/peerj.20701 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PeerJ, 2026. Verfasst von Yang Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Glutamine, Osteoarthritis, Metabolic Networks and Pathways, Gene Regulatory Networks. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chongqing Hospital of Traditional Chinese Medicine, Chongqing Jiangjin District Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The understanding of the pathogenesis of osteoarthritis (OA) is often fragmented, with studies focusing on individual tissues. A holistic view integrating multi-tissue molecular changes with systemic metabolic shifts is urgently needed. Glutamine metabolism, a central bioenergetic and biosynthetic hub, represents a critical but largely unexplored nexus in this disease network. This study leverages a multi-omics, multi-tissue approach to deconstruct the role of glutamine metabolism in OA and identify a robust, blood-based signature for potential diagnostic use.

Methods

We conducted a comprehensive bioinformatic investigation by integrating multiple GEO transcriptomic datasets from cartilage, synovium, subchondral bone, and peripheral blood. A machine learning pipeline, incorporating weighted gene co-expression network analysis (WGCNA) and least absolute shrinkage and selection operator (LASSO) regression, was employed to identify a signature of glutamine metabolism-related genes (GMRGs). The signature’s clinical relevance was then validated in an independent cohort of 62 subjects (31 OA patients vs . 31 healthy controls) using RT-qPCR on peripheral blood samples and plasma metabolomics. Furthermore, we computationally explored its potential regulatory mechanisms and predicted candidate therapeutic compounds.

Results

Our multi-layered analysis identified a core three-gene signature ( F13A1 , IRS2 , RELA ). Functional analysis linked this signature to pathways essential for OA pathogenesis, including mechanical stress, metabolic regulation, and inflammatory responses. Clinical validation in an independent cohort confirmed significant downregulation of all three genes in OA peripheral blood ( P < 0.001) and revealed distinct regulatory patterns, including disease-specific activation of RELA and a metabolic regulatory reversal of IRS2 , as well as negative correlations with disease severity and alterations in circulating glutamine-related metabolites. The resulting diagnostic model showed strong discriminatory performance across both training and validation datasets. Plasma creatine emerged as an independent predictor of disease severity. Finally, exploratory analyses suggested potential epigenetic regulation and identified several candidate drugs capable of modulating the signature.

Conclusions

This study identifies a blood-based, multi-omics-derived gene signature that links localized joint pathology with systemic metabolic dysfunction in osteoarthritis. The signature offers a robust non-invasive diagnostic marker and reveals new opportunities for patient stratification and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutamineOsteoarthritisMetabolic Networks and PathwaysGene Regulatory NetworksMultiomicsComputational BiologyBiomarkersMachine LearningTranscriptomeInsulin Receptor Substrate ProteinsTranscription Factor RelADown-RegulationSeverity of Illness IndexEpigenesis, GeneticCase-Control StudiesProspective StudiesDNA MethylationHumansMaleFemaleMiddle Aged

Stichwörter der Autor:innen

Diagnostic biomarkersGlutamine metabolismMetabolic reprogrammingMulti-omics analysisOsteoarthritis

Substanzen

GlutamineBiomarkersIRS2 protein, humanRELA protein, humanInsulin Receptor Substrate ProteinsTranscription Factor RelA

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, China.
  • Chongqing Jiangjin District Hospital of Traditional Chinese Medicine, Chongqing, China.
  • Chongqing Key Laboratory of Traditional Chinese Medicine to Prevent and Treat Autoimmune Diseases, Chongqing, China.
  • Department of Rheumatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.

Förderung

  • Chongqing Hospital of Traditional Chinese Medicine
  • Chongqing Jiangjin District Science and Technology Program

Zitieren

APA

Lu, Y., Liu, J., Wang, S., Gan, J., Cao, W., & Wu, B. (2026). Identification and validation of a glutamine metabolism-related gene signature as a diagnostic and therapeutic target in osteoarthritis through integrated multi-omics analysis. PeerJ. https://doi.org/10.7717/peerj.20701

Vancouver

Lu Y, Liu J, Wang S, Gan J, Cao W, Wu B. Identification and validation of a glutamine metabolism-related gene signature as a diagnostic and therapeutic target in osteoarthritis through integrated multi-omics analysis. PeerJ. 2026. doi:10.7717/peerj.20701

BibTeX
@article{Lu2026,
  author = {Lu, Yang and Liu, Jinkun and Wang, Shasha and Gan, Jianping and Cao, Wenfu and Wu, Bin},
  title = {Identification and validation of a glutamine metabolism-related gene signature as a diagnostic and therapeutic target in osteoarthritis through integrated multi-omics analysis},
  journal = {PeerJ},
  year = {2026},
  doi = {10.7717/peerj.20701}
}
Kostenlos starten →